Finzati - Logo
VTRS logo

Viatris Inc.

VTRS • Drug Manufacturers - Specialty & Generic
$16.88
▼ -0.06 (-0.35%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$19.64B
Growth
4.0%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 1.65Consistent free cash flow · 5/5Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:24 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$16.88
Change-0.35%
Shares Out1.16B
Market Cap$19.64B
Enterprise Value$32.10B
52W Range8.80 - 18.39
Beta0.90
P/E-47.81
P/S1.33
P/B1.38
P/FCF9.18
EV/Sales2.18

Investment DNA

How strong this company looks for long-term investors

53
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
48/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive free cash flow · 1.65Consistent free cash flow · 5/5Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

VTRS
Analyst sentiment
Based on 13 analyst votes · 2026-09-05
62/100
Neutral
Bullish
4
Hold
8
Bearish
1
Price Target
2026-08-07
Low
$18.00
Mean
$20.00
Median
$20.00
High
$22.00

Company Overview

IPO: 3/17/1980
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 1.38
Debt / Equity i: 1.00
Operating Margin: -18.62%
Net Margin: -24.58%
ROE i: -
ROIC: -

Financial Health

Score10 / 20
Debt / Equity: 1.00
Current Ratio: 1.30
Quick Ratio: 0.74
Status: Moderate

Warnings

  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Groothuis Leo Frans
Transaction: 06/30/2026
BUY
Change
+2,756
Price
Not reported
Filing
07/01/2026
Type
BUY
SIMMONS DAVID S
Transaction: 06/30/2026
BUY
Change
+2,362
Price
Not reported
Filing
07/01/2026
Type
BUY
Campbell Paul
Transaction: 06/25/2026
SELL
Change
-50,076
Price
$16.17
Filing
06/26/2026
Type
SELL